These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17803524)

  • 81. An animal model of pancreatic cancer involving whole pancreas transplantation.
    Sayers HJ; Dail DH; Orloff MJ
    Surg Forum; 1978; 29():122-4. PubMed ID: 401111
    [No Abstract]   [Full Text] [Related]  

  • 82. Experimental pancreatic carcinogenesis.
    Longnecker DS
    Lab Invest; 1982 May; 46(5):543-4. PubMed ID: 6804716
    [No Abstract]   [Full Text] [Related]  

  • 83. Melatonin influences pancreatic cancerogenesis.
    Jaworek J; Leja-Szpak A
    Histol Histopathol; 2014 Apr; 29(4):423-31. PubMed ID: 24258787
    [TBL] [Abstract][Full Text] [Related]  

  • 84. An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress.
    Mehrzadi S; Pourhanifeh MH; Mirzaei A; Moradian F; Hosseinzadeh A
    Cancer Cell Int; 2021 Mar; 21(1):188. PubMed ID: 33789681
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Different Effects of Melatonin on X-Rays-Irradiated Cancer Cells in a Dose-Dependent Manner.
    Zhu H; Chen Y; Bai LC; Cao XR; Xu R
    Dose Response; 2019; 17(3):1559325819877271. PubMed ID: 31579126
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Mechanisms Underlying Tumor Suppressive Properties of Melatonin.
    Bondy SC; Campbell A
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060531
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Translational pancreatic cancer research: A comparative study on patient-derived xenograft models.
    Rubio-Manzanares Dorado M; Marín Gómez LM; Aparicio Sánchez D; Pereira Arenas S; Praena-Fernández JM; Borrero Martín JJ; Farfán López F; Gómez Bravo MÁ; Muntané Relat J; Padillo Ruiz J
    World J Gastroenterol; 2018 Feb; 24(7):794-809. PubMed ID: 29467550
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
    Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evaluating the Oxidative Stress in Inflammation: Role of Melatonin.
    Sánchez A; Calpena AC; Clares B
    Int J Mol Sci; 2015 Jul; 16(8):16981-7004. PubMed ID: 26225957
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report.
    Guais A; Baronzio G; Sanders E; Campion F; Mainini C; Fiorentini G; Montagnani F; Behzadi M; Schwartz L; Abolhassani M
    Invest New Drugs; 2012 Feb; 30(1):200-11. PubMed ID: 20931262
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Extended exposure to dietary melatonin reduces tumor number and size in aged male mice.
    Sharman EH; Sharman KG; Bondy SC
    Exp Gerontol; 2011 Jan; 46(1):18-22. PubMed ID: 20837128
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.
    Hofseth LJ
    Cancer Lett; 2008 Sep; 268(1):10-30. PubMed ID: 18440130
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effects of capecitabine and celecoxib in experimental pancreatic cancer.
    Arjona-Sánchez A; Ruiz-Rabelo J; Perea MD; Vázquez R; Cruz A; Muñoz Mdel C; Túnez I; Muntané J; Padillo FJ
    Pancreatology; 2010; 10(5):641-7. PubMed ID: 21051919
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin.
    Gitto E; Pellegrino S; Gitto P; Barberi I; Reiter RJ
    J Pineal Res; 2009 Mar; 46(2):128-39. PubMed ID: 19054296
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Beneficial properties of melatonin in an experimental model of pancreatic cancer.
    Ruiz-Rabelo JF; Vázquez R; Perea MD; Cruz A; González R; Romero A; Muñoz-Villanueva MC; Túnez I; Montilla P; Muntané J; Padillo FJ
    J Pineal Res; 2007 Oct; 43(3):270-5. PubMed ID: 17803524
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Melatonin and celecoxib improve the outcomes in hamsters with experimental pancreatic cancer.
    Padillo FJ; Ruiz-Rabelo JF; Cruz A; Perea MD; Tasset I; Montilla P; Túnez I; Muntané J
    J Pineal Res; 2010 Oct; 49(3):264-70. PubMed ID: 20626589
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Improvement of capecitabine antitumoral activity by melatonin in pancreatic cancer.
    Ruiz-Rabelo J; Vázquez R; Arjona A; Perea D; Montilla P; Túnez I; Muntané J; Padillo J
    Pancreas; 2011 Apr; 40(3):410-4. PubMed ID: 21178648
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.